Biomarkers · Inflammation
Procalcitonin
Lower values carry lower risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.52top vs bottom quarter (95% CI 1.07–2.16) · Malmö Diet and Cancer study, n=3,322 apparently healthy men, median follow-up 16.2 years
Where people sit
Population percentiles (ng/mL) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 0.01 | 0.01 | 0.02 | 0.05 | 0.18 | 920 | 2017-2018 |
| All | 40-59 | 0.01 | 0.02 | 0.03 | 0.06 | 0.25 | 900 | 2017-2018 |
| All | 60+ | 0.01 | 0.02 | 0.04 | 0.07 | 0.32 | 980 | 2017-2018 |
| All | all | 0.01 | 0.02 | 0.03 | 0.06 | 0.25 | 2,800 | 2017-2018 |
| Men | all | 0.01 | 0.02 | 0.03 | 0.06 | 0.25 | 1,350 | 2017-2018 |
| Women | all | 0.01 | 0.02 | 0.03 | 0.06 | 0.25 | 1,450 | 2017-2018 |
Sources
- Hazard curve: Synthesized from mortality_association (HR=1.52 quartile_extreme); per-SD log(HR)=0.327. Reported as quartile_extreme HR=1.52 for all-cause mortality. Highest vs lowest quartile of plasma procalcitonin in men, adjusted for cardiovascular r
- Melander O, Newton-Cheh C, Almgren P, et al. Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study. BMC Medicine. 2013;11:180.